Nauset Wealth Management »

Alnylam Pharmaceuticals shares owned by Nauset Wealth Management

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Nauset Wealth Management from 13F filings

Historical chart of Nauset Wealth Management investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Nauset Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Nauset Wealth Management

Quarter filed Position value Share count Share price at filing
2022-03-31 $75k 460 163.04

More positions owned by Nauset Wealth Management

Amazon (AMZN)
Select Sector Spdr Tr Sbi Int-inds (XLI)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Core S&p500 Etf (IVV)
Abrdn Etfs Bbrg All Commdy (BCD)
Apple (AAPL)
Blackstone Group Inc Com Cl A (BX)
Ishares Gold Tr Ishares New (IAU)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf (KBWB)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Intl Ftse Dev Mkt Etf (VEA)
Ishares Tr S&p Mc 400vl Etf (IJJ)
American Tower Reit (AMT)
Spdr Ser Tr S&p Bk Etf (KBE)
Vanguard Index Fds Sm Cp Val Etf (VBR)

View all positions for Nauset Wealth Management

Top funds holding Alnylam Pharmaceuticals

Vanguard Group
Wellington Management Company
Baillie Gifford & Co
Dodge & Cox
T. Rowe Price Associates
Jpmorgan Chase & Co
Norges Bank Investment Management
venBio Select Advisor
Legal & General Group
Bellevue Group
Bank of New York Mellon
Ubs Global Asset Management Americas
Amundi
Gilder, Gagnon, Howe & Co
Alliancebernstein

View all funds holding Alnylam Pharmaceuticals